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et al., 2003). Such analyses demonstrate that loss of
these individual genes can block hematopoiesis, al-
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kemias bearing an MLL translocation comprise a distinct
disease characterized by the unique coexpression ofThe Mixed-Lineage Leukemia (MLL) gene encodes a
Trithorax-related chromatin-modifying protooncogene early lymphoid progenitor-associated genes as well as
myeloid-specific genes (Armstrong et al., 2002), sug-that positively regulates Hox genes. In addition to their
well-characterized roles in axial patterning, Trithorax gesting immortalization of an early multipotent progeni-
tor. The precise mechanism by which Trithorax groupand Polycomb family proteins perform less-under-
stood functions in vertebrate hematopoiesis. To define proteins act to maintain different target genes is not yet
clear, nor is the range of tissue-specific Mll-dependentthe role of MLL in the development of the hematopoi-
etic system, we examined the potential of cells lacking gene programs. Mll is expressed in most fetal and adult
hematopoietic cell types throughout development, in-MLL. Mll-deficient cells could not develop into lympho-
cytes in adult RAG-2 chimeric animals. Similarly, in cluding stem cell and progenitor populations (Kawagoe
et al., 1999; Phillips et al., 2000). When hematopoiesisvitro differentiation of B cells required MLL. In chimeric
embryos, Mll-deficient cells failed to contribute to fetal was examined, reduced clonogenic capacity was dem-
onstrated in Mll-deficient progenitors in the yolk sacliver hematopoietic stem cell/progenitor populations.
Moreover, we show that aorta-gonad-mesonephros (Hess et al., 1997) and fetal liver (Yagi et al., 1998). Using
a different allele of Mll, enhanced clonogenic capacity(AGM) cells from Mll-deficient embryos lacked hema-
topoietic stem cell (HSC) activity despite their ability to in homozygous mutant embryoid bodies was reported
(Fidanza et al., 1996). Although the exact cause of thegenerate hematopoietic progeny in vitro. These results
demonstrate an intrinsic requirement for MLL in defini- early embryonic death of homozygous Mll mutants is
uncertain, they exhibit pleiotropic defects in multipletive hematopoiesis, where it is essential for the gener-
ation of HSCs in the embryo. tissues (Yagi et al., 1998; Yu et al., 1998, 1995). Conse-
quently, the defects in hematopoeitic populations in
such embryos may have been influenced by cell-extrin-Introduction
sic factors.
To assess Mll-dependent functions intrinsic to hema-The development of the hematopoietic system in verte-
brates occurs at several distinct anatomic sites during topoietic lineages, we analyzed chimeric fetal and adult
animals reconstituted with Mll-deficient or heterozygousembryogenesis, providing populations that meet the
needs of the rapidly developing embryo. During this embryonic stem (ES) cells. In this context, we demon-
strated a cell-intrinsic requirement for MLL in the gener-dynamic developmental process, HSCs and progenitors
with distinct properties are generated transiently (Godin ation of lymphoid and myeloid populations in adult ani-
mals, and found a surprisingly stringent requirementand Cumano, 2002; Palis and Yoder, 2001). The potential
utility of manipulating such pathways in normal and ma- for MLL in generating fetal HSC/progenitor populations.
The lack of Mll-deficient HSC/progenitor populations inlignant hematopoiesis warrants a complete understand-
ing of the genetic pathways involved in the generation the fetal liver is preceded by a deficiency in HSCs in the
AGM region, an intraembryonic site in which definitiveand maintenance of HSCs. Genes found at sites of chro-
mosomal translocations in human leukemias have coin- HSCs are localized (reviewed in Godin and Cumano,
2002). These results demonstrate that MLL is requiredcided with genes critical for early steps of hematopoie-
tic commitment (Elefanty et al., 1997; Orkin et al., 1999). during embryogenesis for the specification or expansion
of hematopoietic stem cells.Genes identified in this manner include AML-1 (Runx-1/
CBF), LMO-2 (rbtn-2, Ttg-2), SCL/TAL-1, and TAN-1/
Notch-1, all of which have subsequently been shown Results
to be critical for embryonic hematopoiesis in murine
knock-out studies (Godin and Cumano, 2002; Kumano Lymphopoiesis in the Absence of MLL
To examine lymphopoiesis in the absence of MLL
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Mll/, Supplemental Figures S1 and S2 [http://www. We next analyzed Mll-deficient embryos to determine
whether definitive HSCs were produced prior to the fetaldevelopmentalcell.com /cgi /content /full /6/3/437/DC1])
were injected into RAG-2-deficient blastocysts (Chen et liver stage of hematopoiesis.
al., 1993). Mll/ ES cells developed into B220IgM B
lymphocytes in the spleen (Figure 1A) as well as in the Pre-Liver, Intraembryonic Hematopoiesis
lymph nodes, peripheral blood, and peritoneum (data in the Absence of MLL
not shown). In contrast, no B220 cells were present in The precise origin of definitive HSCs that seed the fetal
spleens of Mll/ chimeras (Figure 1A). Using a stromal liver is not completely resolved (Godin and Cumano,
coculture system, Mll/ ES clones yielded a brief wave 2002; Palis and Yoder, 2001). Using appropriate recipi-
of erythropoiesis, but no B lymphopoiesis (Figure 2 and ents, several hematopoietic populations including the
Supplemental Figure S4). An analysis of developing AGM region have been shown to harbor HSCs (Cumano
T cells demonstrated that Mll/ ES cells give rise to et al., 1996; Muller et al., 1994; Rodewald et al., 1994;
CD4CD8 double positive (DP) thymocytes, as well Yoder et al., 1997). Transplantation of AGM-derived cells
as CD4 and CD8 single positive (SP) thymocytes. In can serve as an important functional test for HSC activity
contrast, Mll/ ES clones produced neither SP nor DP in embryos exhibiting early lethality (Cai et al., 2000;
thymocytes (Figure 1B). These results demonstrate a Kumano et al., 2003). Therefore, to assess HSCs prior
cell-intrinsic block in lymphopoiesis when competition to the fetal liver stage of hematopoiesis, we performed
with host lymphocytes is eliminated (as in the RAG-2 a phenotypic and functional analysis of AGM cells from
chimeras) or even when competition with progenitors is Mll/ embryos.
eliminated (as in the OP9 cocultures). The peak of HSC activity in the AGM occurs at E11–
The complete absence of B and T cells in Mll/ chime- 11.5, and can be enriched by sorting for cells that ex-
ras prompted us to examine other hematopoietic popu- press c-Kit, CD34, CD45, PECAM/CD31, or Runx-1 (De-
lations in MLL-deficient chimeras using the pan-leuko- lassus et al., 1999; Kumaravelu et al., 2002; North et al.,
cyte, strain-specific marker Ly9.1 (Miller et al., 1985). 2002; Sanchez et al., 1996). AGM cells from Mll-deficient
Chimeras generated with Mll/ ES cells exhibited a embryos exhibited a reduction in many of these markers
mixture of ES-derived (Ly9.1DX5, boxed) and host- relative to Mll/ littermate controls, although c-Kit cells
derived (Ly9.1negDX5) NK cells, whereas NK cells were were not reduced overall (Figure 3A). Runx-1 expression
not produced from Mll/ ES cells (Figure 1C). Similarly, in the dorsal aorta, as detected by in situ hybridization,
Mll/ ES clones did not contribute to peritoneal macro- was reduced, yet the endothelium appeared otherwise
phage populations (data not shown). Collectively, these intact (Figures 2B–2G).
results indicate that the multilineage block observed in In short-term explant cultures, we found that Mll-defi-
adult MLL-deficient chimeras is due to a requirement cient E11.5 AGM cells consistently produced some
for MLL at a multipotent progenitor or stem cell stage. CD45 hematopoietic cells that differentiated into mac-
rophages, whereas wild-type cultures produced a range
of myeloid cell types in these culture conditions (FigureAnalysis of Fetal Liver Chimeras Identifies an Early
4A). To determine whether HSCs were produced in MLL-Mll-Dependent Step in Hematopoiesis
deficient embryos, we transplanted E11.5 AGM cells intoTo more easily assess progenitor and HSC populations
sublethally irradiated RAGC/ recipients. AGM cellsin vivo, we analyzed fetal hematopoiesis in chimeras
derived from Mll/ littermates efficiently reconstitutedgenerated from lacZ marked Mll/ and Mll/ ES clones
most recipients (75%) and persisted for greater than(Supplemental Figure S2) injected into wild-type blasto-
6 months. In contrast, none of the recipients of Mll/cysts. Using the ES strain-specific Ly9.1 cell surface
AGM cells were significantly reconstituted (Figure 4B).marker, we found that Mll-deficient ES clones did not
Donor-derived cells in Mll/ AGM-engrafted recipientscontribute to any lineage-positive (Gr-1, CD11b,
could not be detected within erythroid, myeloid, orB220, CD19, DX5, or CD3, data not shown) cells in
lymphoid populations of peripheral blood (Supplementalembryonic day (E) 14–15 chimeras. Therefore, we ana-
Figure S5 and data not shown). Unexpectedly, onlylyzed individual fetal livers from chimeric embryos for
two of nine recipients engrafted with Mll/ AGM cellscontribution to the lineage-negative, c-Kit-positive pool
yielded any detectable donor contribution (Figure 4B).that includes both HSC and progenitor populations
One of these two cases exhibited transient reconstitu-(Morrison et al., 1995; Traver et al., 2001). To determine
tion and the other exhibited low-level reconstitutionoverall chimerism, we incubated embryos with X-Gal to
(Supplemental Figure S5). Thus, Mll haploinsufficiencyreveal cells of ES origin (Figures 2E and 2F). Embryos
is incompatible with the generation of HSCs at normalderived from Mll/ ES cell injections varied in their de-
frequencies in the E11.5 AGM. Together, these datagree of chimerism, but always gave rise to lineage-nega-
indicate that MLL deficiency blocks the generation oftive, c-Kit/Ly9.1 cells in proportion to the degree of
functional HSCs in the AGM.chimerism (Figure 2E). In sharp contrast, Mll-deficient
chimeras exhibited background levels of lineage-nega-
tive, c-Kit ES-derived cells, despite high levels of over- Discussion
all chimerism (Figure 2F).
These data demonstrate a cell-autonomous require- In the present study, we demonstrate a cell-intrinsic
requirement for MLL in the development of definitivement for the Mll gene in fetal liver hematopoiesis. Given
the stringency of this requirement, it is possible that hematopoietic cells. Using chimeric animals, we show
that Mll-deficient cells fail to generate adult lymphoidMll-deficient HSCs either fail to populate the fetal liver
rudiment or may arrive but fail to expand competitively. and myeloid cells, and that even fetal HSC/progenitor
Hematopoiesis in the Absence of MLL
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Figure 1. MLL-Deficient ES Cells Fail to Reconstitute Hematopoietic Organs in Chimeric Animals
(A) Spleen cells of two representative mice for control (Mll/→RAG) or Mll-deficient (Mll/→RAG) chimeras were analyzed by flow cytometry.
Control 129SvJ strain (wild-type) and RAG-2 animals were analyzed in parallel (left panels).
(B) Cells from the thymus of two representative chimeras were analyzed as in (A) using the indicated antibodies.
(C) Spleen cells of two representative control (Mll/→RAG) or Mll-deficient (Mll/→RAG) chimeras were analyzed by flow cytometry to reveal
ES-derived NK cells (boxed). All experiments are representative of more than 40 chimeric animals (based on coat color and PCR-positive tail
biopsies) analyzed per genotype.
(D) Control Mll/ embryo at E14.5 stained with X-Gal to demonstrate maximum lacZ expression, and control flow cytometry analysis of wild-
type 129SvJ E14.5 fetal liver. Fetal liver cells were analyzed by excluding lineage-positive cells using a cocktail of lineage-specific antibodies
(Supplemental Data) and the remaining cells are shown stained with Ly9.1 (y axis) and c-Kit (x axis). The percentage of lineage-negative cells
that were c-Kit/Ly9.1 (boxed) is shown.
(E) Three individual chimeric embryos generated with Mll/ ES cells are shown next to results of flow cytometry performed as described above.
(F) Three individual chimeric embryos generated with Mll/ ES cells, and flow cytometry results as in (D). The embryos shown are representative
of the range of chimerism observed in all experiments.
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Figure 3. Phenotypic and Functional Consequences of MLL Defi-
ciency in Cells of the AGMFigure 2. OP9 Coculture Demonstrates Cell-Autonomous Block in
B-Lymphopoiesis from Mll-Deficient ES Cells (A) Cell populations in dissociated E11.5 AGM cells were quantified
by flow cytometry. Individual AGM regions were dissected, dissoci-(A) Scheme and factors used for differentiating ES cells to B cells.
ated, and analyzed by flow cytometry (see Experimental Proce-(B) Phase-contrast image of mesodermal (top panels, 40 magnifi-
dures). Values shown are averages of two to five individual embryoscation) and hematopoietic colonies (lower panels, 100 magnifica-
within a single litter. Results were reproduced using at least threetion). Cultures were fixed and stained with X-Gal to reveal mesoder-
different litters.mal colonies at day 5, or photographed live at day 12. Most
(B and C) In situ hybridization revealing Runx-1 transcripts in thesuspension cells were Ter119 at day 12 (Supplemental Figure S4).
dorsal aorta of the AGM region of Mll/ (B) and Mll/ (C) E10.5(C) Time course analysis of B220-positive cells produced in cocul-
embryos photographed at 600 magnification.ture experiments. Cultures from two independent Mll/ ES clones
(D–G) Immunohistochemistry using anti-PECAM/CD31 antibodiesare shown (dark and light red bars), one Mll/ ES clone (blue), and
on adjacent sections of Mll/ (D and F) or Mll/ (E and G) embryos.wild-type ES cells (green). Data from one representative experi-
The low-power view of the embryo section is shown in (F) and (G)ment of three are shown. Control (Mll/) cells were 60%
for orientation. Dorsal mesentery of the hindgut (dm), urogenitalB220AA4.1CD19 (Supplemental Figure S4).
ridges (u), and mesonephric tubules (arrows) are labeled. All results
were reproduced using multiple sections from at least two embryos
pools cannot develop in the absence of MLL. Moreover, per genotype.
the deficit of HSC activity within both the Mll/ and
Mll/ AGM indicates that a critical threshold level of
MLL is required for the development of normal numbers
of HSCs in the embryo.
Hematopoiesis in the Absence of MLL
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While short-term in vitro assays reveal that some
myeloid and erythroid differentiation can occur in the
absence of MLL, our in vivo approaches found no contri-
bution of Mll-deficient cells to myeloid or erythroid
populations in either chimeric animals or recipients of
AGM cells. The striking defect in HSC activity in vivo,
in concert with these observations, place the block in
definitive hematopoiesis at the development of the HSC
itself and/or in the transition from HSC to multipotent
progenitor.
Comparison of the phenotype described here to other
loss-of-function models of genes critical for embryonic
hematopoiesis positions Mll within a select set of genes
required for all definitive blood lineages in the embryo.
Disruption of the c-Myb (Sumner et al., 2000), Lmo-2
(Yamada et al., 1998), Gata-2 (Tsai et al., 1994), Runx-1
(Okuda et al., 1996), or SCL gene (Porcher et al., 1996)
results in a cell-intrinsic block in all definitive blood lin-
eages when tested in blastocyst chimeras, as shown
here for Mll. The Lmo-2-, SCL-, Notch-1-, and GATA-2-
deficient embryos exhibit earlier lethality than the Mll
mutants reported here, possibly due to more severe
effects on vasculogenesis or embryonic erythropoiesis.
Mll- and Runx-1-deficient embryos both lack fetal liver
hematopoiesis with primitive erythropoiesis remaining
relatively unaffected (Hess et al., 1997; Okuda et al.,
1996; Wang et al., 1996; Yagi et al., 1998; this study).
Furthermore, Mll- and Runx-1-heterozygous embryos
both exhibit defects in the generation of HSC in the
E11.5 AGM although the temporally disordered develop-
ment of HSCs in the Runx-1/ embryo contrasts with
the consistent reduction in HSC or progenitor numbers
in the Mll/ embryo (Cai et al., 2000; Hess et al., 1997;
Yagi et al., 1998; this study). Further experiments will
clarify the relationships between MLL-dependent gene
programs and those of other genes in this group.
Mll regulates the expression of several Hox genes
including Hoxa7, a9, a10, c6, c8, and c9 (Hanson et al.,
1999; Nakamura et al., 2002; Yagi et al., 1998; Yu et
al., 1998, 1995). Both loss- and gain-of-function studies
have indicated that Hox genes play important roles in
regulating HSC numbers, progenitor expansion, and lin-
eage choice (Buske and Humphries, 2000). Thus, one
explanation for the severe block in definitive hematopoi-
esis in Mll-deficient animals is that a particular subset
of critical Hox genes is under- or mis-expressed at an
early stage of blood development. Expression of selectFigure 4. Mll-Deficient AGM Cells Can Generate Hematopoietic
Hox A, B, and C genes has been reported in early boneProgeny but Lack HSC Activity
marrow and fetal hematopoietic populations (Kawagoe(A) Results of short-term explant cultures. Intact AGM from E11.5
embryos were plated on OP9 monolayers. After 2 days of culture, et al., 1999; McGrath and Palis, 1997; Pineault et al.,
cells were trypsinized and allowed to differentiate 2 additional days 2002). To date, no individual or compound Hox gene
with half analyzed by flow cytometry (left column) using CD45 (y knockout recapitulates the block in definitive hemato-
axis) and CD34 (x axis) antibodies. After 8 additional days, modified
poiesis observed in Mll mutants, suggesting that theWright-Giemsa staining of suspension cells was performed (right
Mll-dependent hematopoietic program will prove to becolumn). Data shown are representative of embryos from four differ-
a broader set of target genes, or a specific subset ofent litters.
(B) Reconstitution of RAGC/ recipients with wild-type and Mll- Hox genes.
deficient AGM cells. AGM cell suspensions were prepared from
E11.5 embryos and were injected intravenously into sublethally irra- Experimental Procedures
diated hosts. All wild-type AGM-reconstituted animals exhibited
long-term (20 week) persistence of donor-type cells in at least Embryonic Stem Cell Culture and Differentiation
three lineages. ES cells were maintained on mitomycin-C inactivated feeder layers
in DMEM containing 200 mM nonessential amino acids, 200 mM
L-glutamine, 10 U/ml penicillin G, 10 g/ml streptomycin (Invitro-
gen), 100 M 2-ME (Sigma), 15% fetal bovine serum (Hyclone), and
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400 U/ml ESGRO (Chemicon). Targeting details are described in the References
Supplemental Data). OP9 monolayers were maintained and used to
initiate differentiation of ES cells as described (Cho et al., 1999). Armstrong, S.A., Staunton, J.E., Silverman, L.B., Pieters, R., den
Murine recombinant Flt-3 ligand and IL-7 were used at 20 ng/ml Boer, M.L., Minden, M.D., Sallan, S.E., Lander, E.S., Golub, T.R.,
and 5 ng/ml, respectively; both were purchased from R&D Systems. and Korsmeyer, S.J. (2002). MLL translocations specify a distinct
gene expression profile that distinguishes a unique leukemia. Nat.
Genet. 30, 41–47.
Mouse and Embryo Analyses Biondi, A., Cimino, G., Pieters, R., and Pui, C.H. (2000). Biological
Flow cytometry was performed using standard methods with a Bec- and therapeutic aspects of infant leukemia. Blood 96, 24–33.
ton Dickinson FACSCalibur and FlowJo software. RAG-2 chimeras
Birren, S.J., Lo, L., and Anderson, D.J. (1993). Sympathetic neuro-were analyzed between 4 and 8 weeks of age. Embryo age was
blasts undergo a developmental switch in trophic dependence. De-defined as 0.5 dpc at 8 a.m. the day of vaginal plug observation.
velopment 119, 597–610.LacZ expression in chimeric embryos was revealed by fixing the
Buske, C., and Humphries, R.K. (2000). Homeobox genes in leuke-embryos in 2% paraformaldehyde/0.2% glutaraldehyde/PBS for
mogenesis. Int. J. Hematol. 71, 301–308.1 hr at 4C, washing the embryo in several changes of X-Gal wash
solution (0.1 M phosphate buffer [pH 7.3], 2 mM MgCl2, 0.01% so- Cai, Z., de Bruijn, M., Ma, X., Dortland, B., Luteijn, T., Downing,
dium deoxycholate, and 0.02% NP-40), and then incubating the R.J., and Dzierzak, E. (2000). Haploinsufficiency of AML1 affects the
embryo in X-Gal substrate solution (X-Gal wash solution containing temporal and spatial generation of hematopoietic stem cells in the
5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, and mouse embryo. Immunity 13, 423–431.
1 mg/ml X-Gal) at 37C for 2–6 hr. Embryos were post-fixed in 4%
Chen, J., Lansford, R., Stewart, V., Young, F., and Alt, F.W. (1993).
paraformaldehyde/PBS for 1 hr at 4C and photographed at 7
RAG-2-deficient blastocyst complementation: an assay of gene
magnification. AGM regions of E11.5 embryos were dissected as
function in lymphocyte development. Proc. Natl. Acad. Sci. USA
diagrammed (Medvinsky et al., 1996) and incubated in culture for
90, 4528–4532.
1–4 hr before transplantation. Single-cell suspensions were pre-
Cho, S.K., Webber, T.D., Carlyle, J.R., Nakano, T., Lewis, S.M., andpared by digestion with 0.2% collagenase (Boehringer) for 30 min
Zuniga-Pflucker, J.C. (1999). Functional characterization of B lym-at 37C, or by mechanical dissociation with a 26G syringe in Hank’s
phocytes generated in vitro from embryonic stem cells. Proc. Natl.Balanced Salt Solution (Invitrogen) containing 2% fetal bovine se-
Acad. Sci. USA 96, 9797–9802.rum. Cell suspensions were injected intravenously into 5- to 8-week-
old RAGC/ animals (Taconic) irradiated with a single dose of 450 Cumano, A., Dieterlen-Lievre, F., and Godin, I. (1996). Lymphoid
potential, probed before circulation in mouse, is restricted to caudalcGy from a 137Cesium source. For short-term culture experiments,
the intact AGM was placed on an OP9 stromal layer in IMDM (In- intraembryonic splanchnopleura. Cell 86, 907–916.
vitrogen) containing 50 ng/ml SCF, 10 ng/ml IL-6, and 10 ng/ml Delassus, S., Titley, I., and Enver, T. (1999). Functional and molecular
IL-3 (R&D Systems). After 2 days of explant culture, all cells were analysis of hematopoietic progenitors derived from the aorta-
trypsinized and replated in six-well dishes. Cells were then passaged gonad-mesonephros region of the mouse embryo. Blood 94, 1495–
as necessary. Cytospin preparations were performed with a Cyto- 1503.
spin 3 cytocentrifuge (Shandon) for 4 min at 700 rpm and cells were
Elefanty, A.G., Robb, L., and Begley, C.G. (1997). Factors involved
fixed and stained with Dip-Quick (Jorgensen Laboratories).
in leukaemogenesis and haemopoiesis. Baillieres Clin. Haematol.
10, 589–614.
Fidanza, V., Melotti, P., Yano, T., Nakamura, T., Bradley, A., Canaani,In Situ Hybridization and Immunohistochemistry
E., Calabretta, B., and Croce, C.M. (1996). Double knockout of theE10–11.5 embryos were fixed in 4% paraformaldehyde in phosphate
ALL-1 gene blocks hematopoietic differentiation in vitro. Cancerbuffer (pH 7.2) 4–16 hr, washed in PBS, equilibrated in 15% sucrose/
Res. 56, 1179–1183.phosphate buffer, and then frozen in OCT medium (Tissue-Tek).
Eight to twelve micron sections were cut using a Reichert-Jung Godin, I., and Cumano, A. (2002). The hare and the tortoise: an
Cryocut 1800 and air-dried for1 hr on Superfrost Plus slides (Fisher embryonic haematopoietic race. Nat. Rev. Immunol. 2, 593–604.
Scientific). Nonradioactive in situ hybridization with Runx-1 probe Hanson, R.D., Hess, J.L., Yu, B.D., Ernst, P., van Lohuizen, M., Berns,
was performed as described (Birren et al., 1993). Immunohistochem- A., van der Lugt, N.M., Shashikant, C.S., Ruddle, F.H., Seto, M., and
istry was performed with rat anti-CD31 and developed using an anti- Korsmeyer, S.J. (1999). Mammalian Trithorax and polycomb-group
rat Vectastain kit (Vectastain) and Nova Red substrate (Vector Labs). homologues are antagonistic regulators of homeotic development.
Sections were photographed at 600 total magnification (Figures Proc. Natl. Acad. Sci. USA 96, 14372–14377.
3B–3E) or 40 magnification (Figures 3F and 3G) with a Nikon
Hess, J.L., Yu, B.D., Li, B., Hanson, R., and Korsmeyer, S.J. (1997).Eclipse 6000 microscope using a Spot digital camera.
Defects in yolk sac hematopoiesis in Mll-null embryos. Blood 90,
1799–1806.
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